Drug comparisons
Linagliptin vs Tolbutamide
Compare Linagliptin (Tradjenta) vs Tolbutamide for type 2 diabetes. Differences in mechanism, hypoglycemia risk, side effects, and which may suit patients better.
No comparison dimensions are available for this page.
Clinical context
This comparison occurs when evaluating a switch from older first-generation sulfonylureas like Tolbutamide to modern DPP-4 inhibitors like Linagliptin for type 2 diabetes safety.
Bottom line
Linagliptin typically offers a superior safety profile over Tolbutamide with less hypoglycemia, but neither is universally better without medical input.
All medication comparisons